A retrospective study to evaluate the clinical effectiveness and safety of treatments for Covid-19 hospitalised patients and to determine prognostic factors. (RAPID COVID-19)

Study identification

• PURI:
  https://redirect.ema.europa.eu/resource/35991
• EU PAS number:
  EUPAS35254
• Study ID:
  35991
• Official title and acronym:
  A retrospective study to evaluate the clinical effectiveness and safety of treatments for Covid-19 hospitalised patients and to determine prognostic factors. (RAPID COVID-19)
• DARWIN EU® study:
  No
• Study countries:
  Spain
• Study description:
  RAPID COVID-19 (Retrospective Analysis of Potential Interventions and Determinants). This retrospective study aims to evaluate the clinical effectiveness and safety of various treatments and regimes and prognostic factors in hospitalised patients with COVID-19 in Spain.
• Study status:
  Ongoing

Research institution and networks

Institutions

OXON Epidemiology

Spain

United Kingdom

Study timelines

Date when funding contract was signed

Planned: 25/05/2020

Actual: 19/05/2020

Study start date

Planned: 25/05/2020

Actual: 19/05/2020

Date of final study report

Planned: 24/02/2021

Sources of funding

Other

More details on funding

OXON Epidemiology

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable